Related Experiment Video

Updated: Jul 4, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

p53 brings a new twist to the Smad signaling network

Azeddine Atfi1, Roland Baron

  • 1INSERM U893, Hôpital St-Antoine, 184 Rue du Faubourg St-Antoine, 75571 Paris, France. azeddine.atfi@inserm.fr

Science Signaling
|July 3, 2008
PubMed

Insights

Transforming growth factor beta (TGF-beta) signaling and the tumor suppressor p53 cooperate in cell fate decisions. Inactivation of p53 may enable cancer cells to evade TGF-beta

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Cancer Biology

Background:

  • Transforming growth factor beta (TGF-beta) signaling is crucial for cellular processes like development, proliferation, differentiation, and apoptosis.
  • Dysregulation of TGF-beta pathway components is implicated in various cancers and human disorders.
  • The Smad family of proteins are key transcriptional regulators activated by TGF-beta signaling.

Purpose of the Study:

  • To elucidate the role of the tumor suppressor p53 as a partner in TGF-beta signaling.
  • To understand how p53 inactivation affects cellular responses to TGF-beta, particularly in the context of cancer.

Main Methods:

  • Analysis of the interaction between p53 and Smad proteins within the TGF-beta signaling pathway.
  • Investigation of how p53 status influences cellular responses to TGF-beta, including cytostatic effects.
  • Examination of TGF-beta pathway integrity in cancer cells with inactivated p53.

Main Results:

  • p53 acts as an essential partner to Smads, modulating TGF-beta signaling at multiple levels.
  • Inactivation of p53 can lead to cancer cells escaping the growth-inhibitory effects of TGF-beta.
  • This occurs even when TGF-beta receptors and Smads appear functional, highlighting p53's critical role.

Conclusions:

  • p53 and TGF-beta signaling cooperate to regulate cell fate decisions and maintain cellular homeostasis.
  • The interplay between p53 and TGF-beta has significant pathophysiological implications, particularly in cancer development and progression.
  • Understanding this interaction is key to developing targeted cancer therapies.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...